Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,057 public trials 2,038 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes

NCT00331513

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +39 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Use of Topotecan in Patients With Refractory Acute Leukemia

NCT00100477

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: North Florida/South Georgia Veterans Health System Gainesville, Florida, United States

View Trial Details

Completed

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

NCT00457964

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +27 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Completed

Hyper-CVAD Treatment of Adult T-cell Acute Lymphoblastic Leukemia in Sweden.

NCT01950286

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Orebro University Hospital Örebro, Örebro County, Sweden

View Trial Details

Completed

Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma

NCT00938626

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00316940

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Comprehensive Blood and Cancer Center Bakersfield, California, United States

Hematology-Oncology Medical Group of Fresno, Incorporated Fresno, California, United States

West Hollywood, California, United States

Center for Cancer and Blood Disorders at Suburban Hospital Bethesda, Maryland, United States

View Trial Details

Completed

Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction

NCT00547365

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Baptist Regional Cancer Center at Baptist Riverside Knoxville, Tennessee, United States

St. Mary's Medical Center Powell, Tennessee, United States

View Trial Details

Completed

Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia

NCT00281918

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations: Gosford Hospital Gosford, New South Wales, Australia

Westmead Institute for Cancer Research at Westmead Hospital Westmead - Wentworthville, New South Wales, Australia

Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia

Princess Alexandra Hospital Brisbane, Queensland, Australia

View all 162 locations

View Trial Details

Completed

Radioimmunoimaging of Light Chain (AL) Amyloidosis

NCT01815086

Conditions: AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations: University of Tennessee Medical Center Knoxville, Tennessee, United States

View Trial Details

Completed

Radioimmunoimaging of AL Amyloidosis

NCT00807872

Conditions: Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations: University of Tennessee Medical Center Knoxville, Tennessee, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions